Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia.Lidia Gil, Mariusz Wysocki, Beata Rafińska et al.|PubMed|2008Cited by 27
Risk Factors for Transplant Outcomes in Children and Adolescents with Non-Malignant Diseases Following Allogeneic Hematopoietic Stem Cell TransplantationAgnieszka Zaucha‐Prażmo, Jerzy Kowalczyk, Anna Pieczonka et al.|Annals of Transplantation|2019Cited by 14